Ethos Financial Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$371K Buy
26,551
+469
+2% +$6.58K 0.03% 363
2025
Q4
$385K Buy
26,082
+205
+0.8% +$3.08K 0.03% 338
2025
Q3
$412K Buy
25,877
+648
+3% +$10.7K 0.03% 303
2025
Q2
$446K Buy
25,229
+5,004
+25% +$97.5K 0.04% 285
2025
Q1
$386K Hold
20,225
0.04% 285
2024
Q4
$386K Buy
20,225
+6,663
+49% +$128K 0.05% 193
2024
Q3
$265K Sell
13,562
-167
-1% -$3.32K 0.04% 224
2024
Q2
$269K Sell
13,729
-322
-2% -$6.11K 0.05% 216
2024
Q1
$253K Sell
14,051
-4,712
-25% -$85.5K 0.05% 226
2023
Q4
$338K Sell
18,763
-410,347
-96% -$8.15M 0.07% 180
2023
Q3
$8.52M Buy
429,110
+5,588
+1% +$106K 2.2% 14
2023
Q2
$8.64M Hold
423,522
2.92% 9
2023
Q1
$8.64M Sell
423,522
-183,958
-30% -$3.7M 2.69% 9
2022
Q4
$13M Buy
+607,480
New +$12.6M 4.4% 3

Other funds holding BTAL